Skip to main content

Table 1 Baseline characteristics of the patients

From: Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

  N (%) or mean ± SD Reference value
Patients 150  
Age at diagnosis (years) 32.0 ± 1.0  
Male sex 108 (72.0)  
IBD 108 (72.0)  
Overlap with autoimmune hepatitis 13 (8.7)  
Dominant stenosis 100 (66.7)  
Dominant stenosis at first diagnosis 22 (14.7)  
Number of ERCs 618  
Number of ERCs per patient 3.0 ± 0.3  
Laboratory parameters at baseline   
Bilirubin (mg/dL) 0.9 ± 0.3 -1.1
ALT (IU/L) 92.5 ± 9.6 -23
AST (IU/L) 63.7 ± 6.2 -19
AP (IU/L) 252.1 ± 20.2 -175
GGT (IU/L) 267.0 ± 28.5 -60
Albumin (g/dL) 42.0 ± 0.5 35-55
Mayo risk score -0.12 ± 0.1  
  1. IBD, inflammatory bowel disease; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AP, alkaline phosphate; GGT, γ-glutamyltransferase; ERC, endoscopic retrograde cholangiography.